Holen Sie sich die Stockscreener-App
7.89
4.50%
0.34
Schlusskurs vom Vortag:
$7.55
Offen:
$7.4
24-Stunden-Volumen:
20,925
Relative Volume:
0.02
Marktkapitalisierung:
$8.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.28M
KGV:
-0.0834
EPS:
-94.66
Netto-Cashflow:
$-9.80M
1W Leistung:
-3.55%
1M Leistung:
+16.89%
6M Leistung:
+92.91%
1J Leistung:
+47.75%
1-Tages-Spanne:
$7.40
$8.15
1-Wochen-Bereich:
$7.40
$8.25
52-Wochen-Spanne:
$2.098
$23.01
Portage Biotech Inc Stock (PRTG) Company Profile
Firmenname
Portage Biotech Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
7.89 | 13.46M | 0 | -67.28M | -9.80M | -94.66 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-21 | Eingeleitet | Oppenheimer | Outperform |
| 2021-09-02 | Eingeleitet | B. Riley Securities | Buy |
| 2021-08-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Aktie (PRTG) Neueste Nachrichten
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - Asianet Newsable
Investing in Portage Biotech Inc (PRTG) Is Getting More Attractive - knoxdaily.com
Market Analysts see Portage Biotech Inc [PRTG] gaining to $26. Time to buy? - dbtnews.com
Portage Biotech (PRTG) Reports Promising Preclinical Results for PORT-7 | PRTG Stock News - GuruFocus
Insider Activity Signals Optimism for Portage Biotech (PRTG) - GuruFocus
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish By Stocktwits - Investing.com India
Portage Biotech Reports Confirmatory Preclinical Results in Meso - GuruFocus
The Future of Portage Biotech Inc: Analyzing PRTG - investchronicle.com
How analysts predict Portage Biotech Inc (PRTG) will perform this quarter? - uspostnews.com
Portage Biotech Stock Surges As It Prepares For Human Trial - Benzinga
Portage Biotech stock soars on promising preclinical results By Investing.com - Investing.com Nigeria
Portage Biotech stock soars on promising preclinical results - Investing.com Australia
Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study - TipRanks
Top Premarket Gainers - marketscreener.com
Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
New Cancer Breakthrough: PORT-7 Outperforms Standard Treatment in Mesothelioma Study - Stock Titan
Insider Stock Buying Reaches US$2.15m On Portage Biotech - Yahoo
Portage Biotech Inc (PRTG) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
PRTG Stock on the Rise: A Promising Investment - investchronicle.com
Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Rises By 2,134.8% - Defense World
SoftBank Group (OTCMKTS:SFTBF) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) Short Interest Up 2,600.0% in March - Defense World
Corning Natural Gas (OTCMKTS:CNIG) Shares Pass Below 200-Day Moving Average – Here’s What Happened - Defense World
Scorpio Gold (OTCMKTS:SRCRF) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
CVS Health Corporation (CVS): A Bull Case Theory - Yahoo Finance
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - Yahoo Finance
ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Yahoo Finance
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors - Yahoo Finance
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer - Yahoo Finance
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Small Cap Stocks To Add to Your WatchlistMarch 29th - MarketBeat
Promising Biotech Stocks To Watch Now – March 28th - The AM Reporter
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - Asianet Newsable
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m - simplywall.st
Portage Biotech (NASDAQ:PRTG) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Survey - Defense World
Biotech Firms Celebrate Gains With Promising Trials And Partnerships - Finimize
Satellos Bioscience (TSE:MSCL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga
Finanzdaten der Portage Biotech Inc-Aktie (PRTG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):